Last updated: February 3, 2021
Sponsor: Elucid Bioimaging Inc.
Overall Status: Active - Recruiting
Phase
N/A
Condition
Atherosclerosis
Carotid Artery Disease
Treatment
N/AClinical Study ID
NCT04448353
CRISP
Ages > 18 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Subjects must have two (or more) neck CTAs at least 6 months apart of sufficientquality as documented in the vascuCAP Reading Manual.
- Atherosclerotic plaque must be visualized within the carotid artery.
Exclusion
Exclusion Criteria:
- Subjects without visible plaque within the carotid artery
- Subject with insufficient CTA image quality (defined strictly as documented in thevascuCAP Reading Manual)
Study Design
Total Participants: 800
Study Start date:
March 01, 2019
Estimated Completion Date:
April 30, 2022
Study Description
Connect with a study center
Baltimore VA Medical Center
Baltimore, Maryland 21201
United StatesActive - Recruiting
University of Maryland, Baltimore
Baltimore, Maryland 21201
United StatesActive - Recruiting
Walter Reed National Military Medical Center
Bethesda, Maryland 20814
United StatesActive - Recruiting
Weill Cornell Medicine (Affiliated with New York Presbyterian Hospital)
New York, New York 10065
United StatesActive - Recruiting
University Hospital Harrington (Affiliated with Case Western Reserve University)
Cleveland, Ohio 44106
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.